Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation.
Feugier P, Labouyrie E, Djeridane M, Jenabian A, Dubruille V, Berthou C, Ghandour C, Desablens B, Chaït Y, Casassus P, Delwail V, Ifrah N, Le Mevel A, Lamy T, Brière J, Colonna P, Andrieu JM. Feugier P, et al. Among authors: andrieu jm. Blood. 2004 Nov 1;104(9):2675-81. doi: 10.1182/blood-2004-02-0567. Epub 2004 Jul 1. Blood. 2004. PMID: 15231567 Free article.
Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease: 10-year results of a randomized trial.
le Maignan C, Desablens B, Delwail V, Dib M, Berthou C, Vigier M, Ghandour C, Atmani S, Casassus P, Maisonneuve H, Le Mevel A, Traulle C, Bernard M, Briere J, Colonna P, Andrieu JM. le Maignan C, et al. Among authors: andrieu jm. Blood. 2004 Jan 1;103(1):58-66. doi: 10.1182/blood-2003-05-1611. Epub 2003 Aug 7. Blood. 2004. PMID: 12907440 Free article. Clinical Trial.
Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
Sénécal D, Jais JP, Desablens B, Berthou C, Casassus P, Moles MP, Delwail V, Gastinne T, Colonna P, Andrieu JM. Sénécal D, et al. Among authors: andrieu jm. Cancer. 2008 Feb 15;112(4):846-55. doi: 10.1002/cncr.23247. Cancer. 2008. PMID: 18072259 Free article.
Treatment of patients with advanced or bulky Hodgkin disease with a 12-week doxorubicin, bleomycin, vinblastine, and dacarbazine-like chemotherapy regimen followed by extended-field, full-dose radiotherapy: long-term results of the Groupe Ouest et Est des Leucémies et Autres Maladies de Sang H90-A/B Multicenter Randomized Trial.
Djeridane M, Oudard S, Escoffre-Barbe M, Lacotte-Thierry L, Desablens B, Briére J, Dib M, Cassasus P, Ghandour C, Lamy T, Lejeune F, Simon M, Traullé C, Vigier M, Maisonneuve H, Briére J, Colonna P, Andrieu JM. Djeridane M, et al. Among authors: andrieu jm. Cancer. 2002 Nov 15;95(10):2169-79. doi: 10.1002/cncr.10932. Cancer. 2002. PMID: 12412171 Free article. Clinical Trial.
Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group.
Arakelyan N, Berthou C, Desablens B, de Guibert S, Delwail V, Moles MP, Quittet P, Jais JP, Colonna P, Andrieu JM; Groupe Ouest-Est d'Etude des Leucémies et Autres Maladies du Sang. Arakelyan N, et al. Among authors: andrieu jm. Cancer. 2008 Dec 15;113(12):3323-30. doi: 10.1002/cncr.23979. Cancer. 2008. PMID: 18988286 Free article. Clinical Trial.
Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas: results of a randomized trial.
Arakelyan N, Jais JP, Delwail V, Brière J, Moles-Moreau MP, Sénécal D, Berthou C, Desablens B, Colonna P, Andrieu JM; GOELAMS Hodgkin Lymphoma Network. Arakelyan N, et al. Among authors: andrieu jm. Cancer. 2010 Sep 1;116(17):4054-62. doi: 10.1002/cncr.25295. Cancer. 2010. PMID: 20564152 Free article. Clinical Trial.
Intermediate stage Hodgkin lymphoma in partial remission after three or four courses of doxorubicin, bleomycin, vinblastine dacarbazine: no benefit of one course of intensive chemotherapy before irradiation.
Arakelyan N, Jais JP, Tomowiack C, Colombat P, Berthou C, Desablens B, Moles-Moreau MP, Gastinne T, Quittet P, Casassus P, Le Pourhiet-Le Mevel A, Ghandour C, Brière J, Colonna P, Andrieu JM. Arakelyan N, et al. Among authors: andrieu jm. Leuk Lymphoma. 2013 Jan;54(1):76-82. doi: 10.3109/10428194.2012.701737. Epub 2012 Jul 9. Leuk Lymphoma. 2013. PMID: 22680774 Clinical Trial.
Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiotherapy: ten-year results of the Paris-Ouest-France 81/12 trial, including 262 patients.
Colonna P, Jais JP, Desablens B, Harousseau JL, Brière J, Boasson M, Lemevel A, Casassus P, Le Prisé PY, Guilhot F, Ghandour C, Lejeune F, Andrieu JM. Colonna P, et al. Among authors: andrieu jm. J Clin Oncol. 1996 Jun;14(6):1928-35. doi: 10.1200/JCO.1996.14.6.1928. J Clin Oncol. 1996. PMID: 8656262
228 results